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ABSTRACT 
 
DNA is allied with histone proteins to form nucleosomes and higher order structures available in 
eukaryotes. Histones having amino termini can be modified by acetylation. Acetylation of explicit 
residues of the histones is associated with gene activity and may play a elementary role in 
transcriptional regulation. Bromodomains, motifs found in several eukaryotic transcription factors, 
exclusively interact with acetyl-lysines in histones H3 and H4. p300 is functionally conserved 
transcriptional coactivators for various transcription factors and have intrinsic acetyltransferase 
activity. The covalent alteration of histone tails has regulatory roles in various nuclear processes, 
such as organization of transcription and mitotic chromosome condensation. Among the different 
groups of enzymes identified to catalyze the covalent modification, the most topical additions are the 
histone methyltransferases (HMTases), whose functions are now being characterized. G9A is a novel 
mammalian HMTase that prefer lysine. Specific chromosome translocations commonly found in 
human leukemia engross rearrangements of genes which are implicated in the regulation of 
hematopoiesis. Consequently, the chromosome translocations often results in the expression of gene 
products. 
 
 
Keywords:  Histone acetylation, Histone methylation, p300, G9A 
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INTRODUCTION 
 
Repression hand to hand expression imposes an antagonistic threat on the packagers of DNA and 
nucleosome called Histone is switched on with addition of acetyl and methyl groups.  That the 
histones are regulators in chromosomal activity were considered in the past few years, and increasing 
experimental evidences has also accumulated the view about its reticence activity. “Epigenetic 
memory” says about its importance to maintain distinct cellular identities independent of the constant 
genome content. These states and condition have to be stable overtime and must be inherited through 
cell division. Inheritance and transmission of information that is not stored changes in the genome 
sequence. The molecular basis of epigenetic is complex which involves modifications of the 
activation of certain genes, not the basic structure of DNA. Moreover, the chromatin proteins 
associated with DNA may be activated or silenced. This brings to the account for why the 
differentiated cells in a multi-cellular organism express only the genes that are necessary for their 
own activity. Epigenetic changes are preserved with the division of cell units. Most epigenetic 
changes only occur within the course of one individual organism's periodic lifetime, but, if a 
mutation in the DNA has been caused in sperm or egg cell, shows variations in fertilization, and 
some epigenetic changes are inherited and traversed from one generation to the next. Epigenetic 
information and variation that can be considered as heritable are classified into three distinct types: 
DNA methylation, Histone modifications, as well as non-coding RNA mediated gene silencing. The 
organization of eukaryotic chromatin has a major impact on all nuclear processes involving 
substrates of DNA. Expression of gene is affected by the positioning of individual nucleosomes 
relative to regulatory sequential elements, by the folding of the nucleosomal fiber into higher-order 
structures and compartmentalization of functional domains within the nucleus. The central dogma of 
molecular biology states that the information embedded in the linear nucleotide sequence of DNA 
contains coding information for protein and RNA, as well as regulatory sequences which control 
system biology. An expanded view of epigenetics involves multiple mechanisms interacting to 
collectively establish alternate states of chromatin structure, histone modification, composition of 
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proteins that are associated in transcriptional activity. Instead, chromatin is a dynamic identity which 
is subject to extensive developmental remodeling. However, different epigenetic mechanisms tend to 
cross-influence and reinforce each other in the regulation of the cellular response to environmental 
stimuli as well as endogenous signals. This concerted action of myriad epigenetic events is essential 
for the homeostatic orchestration of the diverse cellular mechanisms. Epigenetic variations include 
the following flow diagram: 
 
EPIGENETIC CHANGES 
 
 
HISTONE MODIFICATION    DNA METHYLATION    Non-coding RNA-mediated 
           gene silencing 
 
Acetylation/Deacetylation Methylation/Demethylation Phosphorylation Ubiquitination 
 
It has been tried to introduce to the role of histones in regulatory reactions which modify the 
structures by introducing methyl group with the help of concerned enzymes that says about the 
comparative expression of SET domain protein G9A of histone methyltransferase with that of p300 
that act as histone acetyltransferase in leukemia cell and human lymphocyte. 
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REVIEW OF LITERATURE 
 
1. Histone Modification and variants 
Histones discovered in 1884 by Albrecht Kossel said histones were dismissed by most as 
inert packing material for eukaryotic nuclear DNA who believed that transcription was 
activated by protein-DNA and protein-protein interactions on largely naked DNA templates, 
in case of bacteria. Then it was demonstrated that eukaryotic histones repress gene 
transcription, and transcriptional activators are for repression. Now it is known that histones 
play both positive and negative roles in expression of genes, which is the base for histone 
code formation. 
In biology, they are highly alkaline proteins found in eukaryotic cell nuclei that package and 
order the DNA into structural units called nucleosomes. A histone variant is distinguishable 
from a core histone by a small number of amino acid changes in it. The incorporation of 
histone variants in place of a core histone contributes to marking regions of the chromatin for 
specialized functions and to reversing the effects of histone methyltransferases. Histone 
proteins have a characteristic 'histone fold domain' which consists of structural motif called 
‘helix-turn-helix’ consisting of 3 alpha helices coupled by loops. Each histone perfectly fits to 
form a heterodimer. N-terminal tails of all histones are of particular interest, since they 
protrude out of the compact structure. These N-terminal tails are generally subjected to a 
variety of post-translational modifications like acetylation, methylation, phosphorylation, 
ubiquitination etc. These marks on histones determine which factors bind to the region of 
DNA and regulate the expression status of the particular locus. Histone genes are transcribed 
from multiple loci which occur as distinct clusters on different chromosomes. 
Five major families of histones includes: H1/H5, H2A, H2B, H3, and H4. Histones H2A, 
H2B, H3 and H4 are known to be the core histones, while H1 and H5 are known as the linker 
histones. 
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Two from each of the core histones assemble to form one octameric nucleosome core 
particle, and 147 base pairs of DNA wrap 1.65 times. H1 known to be the linker binds the 
nucleosome at entry and exit sites of the DNA, locking the DNA into place that allows the 
formation of higher order structure. This involves the wrapping of DNA around nucleosomes 
with approx 50 base pairs of DNA  where each pair of necleosomes is separated. The histones 
when assembled with DNA  is called chromatin. 
 
Table 1: Human histone proteins (Redon C and Pilch D, Curr. Opin. Genet. Dev. 12 (2) 2002) 
Super family Family Subfamily Members 
Linker H1 H1F H1F0, H1FNT, H1FOO, H1FX 
  H1H1 HIST1H1A, HIST1H1B, HIST1H1C, 
HIST1H1D, HIST1H1E, HIST1H1T 
Core H2A H2AF H2AFB1, H2AFB2, H2AFB3, H2AFJ, H2AFV 
  H2A1 HIST1H2AA, HIST1H2AB, HIST1H2AC, 
HIST1H2AD, HIST1H2AE, HIST1H2AG, 
HIST1H2AI, HIST1H2AJ, HIST1H2AK 
  H2A2 HIST2H2AA3, HIST2H2AC 
 H2B H2BF H2BFM, H2BFS, H2BFWT 
  H2B1 HIST1H2BA, HIST1H2BB, HIST1H2BC, 
HIST1H2BD, HIST1H2BE, HIST1H2BF, 
HIST1H2BG, HIST1H2BH, HIST1H2BI, 
HIST1H2BJ, HIST1H2BK, HIST1H2BL, 
HIST1H2BM, HIST1H2BN, HIST1H2BO 
  H2B2 HIST2H2BE 
 H3 H3A1 HIST1H3A, HIST1H3B, HIST1H3C, 
HIST1H3D, HIST1H3E, HIST1H3F, HIST1H3G, 
HIST1H3H, HIST1H3I, HIST1H3J 
  H3A2 HIST2H3C 
  H3A3 HIST3H3 
 H4 H41 HIST1H4A, HIST1H4B, HIST1H4C, 
HIST1H4D, HIST1H4E, HIST1H4F, HIST1H4G, 
HIST1H4H, HIST1H4I, HIST1H4J, HIST1H4K, 
HIST1H4L 
  H44 HIST4H4 
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Histone modification affects the chromosome function through at least two distinct mechanisms: 
 The first mechanism suggests modifications may alter the electrostatic charge of the 
histone that results into a structural change in histones or their binding to DNA.  
 The second mechanism proposes that these binding sites for protein recognition 
modules get modified, like the bromodomains or chromodomains recognizing 
acetylated lysines or methylated lysine, respectively. 
Thus, posttranslational modifications of histones create an epigenetic mechanism for the 
regulation of a variety of normal and disease-related processes.  
1.1. Types of histone modification: 
Histones with a wide variety of posttranslational modifications including but not limited to, 
with lysine acetylation, lysine and arginine methylation, also serine and threonine 
phosphorylation, with lysine ubiquitination and sumoylation (Vasquero 2003). These 
modifications occur basically within the histone amino-terminal tails protruding from the 
surface of the nucleosome as well as on the globular core region (Cosgrove 2004). 
• Histone methylation: 
Histone methylation was first discovered with very little impact on biological phenomenon. It 
was initially studied that the pattern of methylation and its maintenance and relation with the 
kind of histone. Methylation of specific lysine residues in histone tails function as a stable 
epigenetic mark, ranging from transcriptional regulation to heterochromatin assembly. 
Methylation forms can be classified into three different types which occurs in lysine 
(me1,me2 and me3) including three modifications, K9me3, K20me3 and K27me3, where 
these are associated with repressed chromatin in many organisms. 
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• Histone acetylation: 
Acetylation neutralises the positive charge on the amino group of lysine and acts as a binding 
site for proteins (Guenther et al., 2007). There is interplay between histone acetylation and 
active chromatinization. It has been verified directly that transcriptional active genes carry 
acetylated core histones (Hebbes et al., 1988). Acetylation of lysine residues on histones H3 
and H4 leads to the formation of an open structure of chromatin. Histone H4 acetylation is 
distinguished at coding regions of the human genome from heterochromatin in a 
differentiation dependent but transcription independent manner. 
• Histone phosphorylation: 
H1 histones play a significant role in regulating highly ordered chromatin structure and 
regulate gene expression. H1 phosphorylates on serine as well as threonine in their amino and 
carboxyl terminals and alters their interface with DNA. Phosphorylation of H1 destabilizes 
highly ordered chromatin structure which allows other factors to access replication, mitotic 
condensation, and activation of gene. It has been observed that histone H3 phosphorylation at 
threonine 45 goes for replication associated post-translational modification.                    
(Baker et al., 2010). The mechanism of transcriptional activation by phosphorylation is not 
well defined. When negatively charged phosphate groups are added to histone tails which 
neutralizes their basic charge and reduces their affinity for DNA. 
 
• Histone ubiquitination: 
Modified N- and C-terminal tails of histones are generally found in patterns, which brings 
specific effector proteins that change chromatin structure and regulate gene expression. 
Among the four core histones, H2A and H2B are known to be modified by ubiquitin 
conjugation. Ubiquitination of histone H2B (uH2B) on lysine 120 (K120) in humans (Becker 
et al., 2002) and lysine 123 in yeast (O’Connel et al., 2007) has been correlated with augment 
in methylation of lysine 79 (K79) of histone H3 by K79-specific methyltransferase. H2A and 
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H2B which are the regulators of ubiquitylation play roles in gene silencing (ub-H2A) or in 
transcription initiation and elongation (ub-H2B). 
               
 
 Figure 1: Different types of histone modifications (Baker et al., Nat Cell Biol 2010)  
 
2.   Histone lysine methylation and its regulation 
  Histone methylation is divided into two types that targets either arginine or lysine residues. 
Histone arginine methylation involves gene activation where methylases are recruited to 
promoters as coactivators. The dynamic ‘on–off’ nature of histone acetylation, has revealed 
that mammalian histones H3 and H4 were highly methylated with little yield of the methyl 
groups. Arginine residues in histone tails targets for methylation catalyzed by class of 
coactivators which are functionally linked by many nuclear receptors (i.e. CARM1 and 
PRMT1) in vitro. Methylation without altering the overall charge of the histone tails by 
increasing methyl addition (mono, di or tri) increases its basicity and hydrophobicity. 
Methylation of histones is catalyzed by histone methyltransferases (HMTs), where S-
adenosylmethionine (SAM) is used as a cofactor.  
Lysines  can be monomethylated (me1), dimethylated (me2) or trimethylated (me3) on their 
ɛ-amine group, whereas, arginines can be monomethylated (me1), dimethylated (me2s) 
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symmetrically   or  dimethylated (me2a) asymmetrically. The sites of histone methylation 
which are extensively studied, include histone H3 lysine 4 (H3K4), H3K9, H3K27, H3K36, 
H3K79 and H4K20. Arginine (R) methylation sites consist of H3R2, H3R8, H3R17, H3R26 
and H4R3. 
 
Figure 2: Mechanism of histone lysine methylation (Bannister et al., Nature 2001) 
The transcribed region of active genes is associated with various marks that consist of 
H3K9me1, H3K27me1, H3K36me3, H3K79me2/3 and H2BK5me1. H3K9me3 marks the 
silent pericentric heterochromatin. Patterns of histone methylation are recognized through a 
many mechanisms involving interface of the respective KMT complexes with gene-specific 
transcription factors, with modified chromatin,  along with elongating form of RNA 
polymerase II enzyme. 
 
          2.1 Histone 3 lysine 9 (H3K9) methylation: 
Histone H3 lysine 9 (H3K9) methylation is an epigenetic signal that is recognized by HP1 
and correlates with gene silencing. The enzymes that catalyze H3K9 methylation has been 
identified as a second gene-specific function for modification in repression in transcription. 
The reason for H3K9 methylation helps in the initiation and establishment of gene repression 
or is a byproduct for the repressed state remains unknown. Histone H3 lysine 9(H3K9) 
methylation is said to be a crucial epigenetic mark of heterochromatin formation and 
transcriptional silencing. G9A which is a major mammalian H3K9 methyltransferase at 
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euchromatin, is essential for embryogenesis. H3K9 methylation is somewhat, dependent on 
DNA methylation. Recent studies in mammalian cancer cells lack DNA methyltransferase 
enzymes (Dnmts) show reduced levels of H3K9 methylation, attributes to the fact that the 
methyl-CpG-binding protein 1 (MBD1) associates with the H3K9 HKMT, SETDB1 (Zhang 
and Reinberg 2001; Martin and Zhang 2005) 
 
3. Histone methyltransferase: 
Histone methyltransferases (HMT) are the  histone-modifying enzymes like histone-lysine N-
methyltransferase and histone-arginine N-methyltransferase that catalyze the transfer of 
methyl groups to lysine and arginine residues. The affection of methyl groups occurs at 
specific lysine or arginine residues on histones H3 and H4.  Major two types of histone 
methyltranferases exist, lysine-specific domain containing or non-SET domain containing 
and arginine-specific. In both the types of histone methyltransferases, cofactor S-Adenosyl 
methionine (SAM) acts as a cofactor and methyl donor group. In eukaryotic cells, the genome 
is compactly built into chromatin which is composed of DNA and histone proteins. Histone 
methylation is significant biologically because it serves for principal epigenetic modification 
of chromatin that identifies gene expression, genomic stability, and maturation of stem cell, 
development of cell lineage, imprinting of genome, DNA methylation, and cell mitosis. 
Histones are the key protein component of chromatin in the eukaryotic nucleus. These 
proteins endure a host of different post-translational modifications, which have insightful 
effects on the chromatin remodelling. Histone modifications can function either individually 
or combined to rule transcription, replication, repairing of DNA, and programmed cell death. 
Recent studies found that histone arginine and lysine methylation play important role to 
generate modifications in regulating transcription and establishment of heterochromatin.  
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          3.1 Histone methyltransferase in cancer: 
Cancer is supposed as a heterogeneous group of diseases that is characterized by aberrant 
patterns of gene expression. In the last decade, a rising amount of data has pointed to a key 
role for epigenetic alterations in human cancer. Here, the focus is on a subclass of regulators 
of epigenetics, known histone methyltransferases (HMTs). Several HMTs have been linked to 
different types of cancer where in most cases we only have limited knowledge about the 
molecular mechanisms by which the HMTs contribute to disease development. 
( Albert M, Helin K et al, 2009) 
          3.2 SET domain-containing lysine-specific methyltransferase:  
The SET domain which is composed of approximately 130 amino acids are the structures 
involved in methyltransferase activity, the pre-SET as well as the post-SET domains. The 
SET domain on either side is flanked by the pre-SET and post-SET domains. The pre-SET 
region consists of cysteine residues forming triangular zinc clusters where the structure is 
stabilized. The β-strands found in the pre-SET domain shape up into β-sheets with the β-
strands of the SET domain that leads to slight variations in the SET domain structure. These 
small changes modify the target residue site specificity for methylation and permit the SET 
domain methyltransferases to target many different residues. This interaction between the 
pre-SET domain and the catalytic core is grave for enzyme to function. In order to proceeds 
the reaction, S-Adenosyl methionine (SAM) and the lysine residue of the histone tail must 
first be bound and it should be oriented in the catalytic pocket of the SET domain. The chain 
of lysine residue then goes for a nucleophilic attack on the methyl group on top of the sulfur 
atom of the SAM molecule where the methyl group is transferred to the lysine side chain. 
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           3.3 Role in gene regulation:  
Transcription is either repressed or activated by methylated histones as suggested by different 
experiments. The methylation of lysine 9 on histone H3 (H3K9me3) in the promoter region 
of genes is likely to prevent excessive expression of these genes and cell cycle transition 
and/or proliferation is delayed. Abnormal expression or activity of methylation-adaptable 
enzymes has been found in some types of human cancers, showing associations between 
histone methylation and malignant alteration of cells or formation of tumors. Epigenetic 
modifications of the histone proteins, particularly the methylation of the histone H3 progress 
for cancer development. With genetic aberrations, cancer can also be initiated by epigenetic 
changes where gene expression is altered in absence of genomic abnormalities. These 
epigenetic says about include loss or gain of methylation in DNA and histone proteins. 
There is not yet convincing facts that suggest cancers expand purely by abnormalities in 
histone methylation or its signaling pathways, however they may be a causal factor.      
Down-regulation of methylation of lysine 9 on histone 3 (H3K9me3) has been experientially 
seen in several types of human cancer (such as colorectal cancer, ovarian cancer, and lung 
cancer), which occur from either the deficiency of H3K9 methyltransferases or eminent 
activity or expression of H3K9 demethylases. 
           3.3 Histone lysine methyltransferases: 
Methylation of lysines residues is known to take place on histone H3 (K4, K9 and K27) and 
H4 (K20). The SUV39 protein was the first histone methyltransferase to be revealed. The 
methyltransferase activity of SUV39 is intended against lysine 9 of histone H3 and its 
catalytic domain resides inside a highly preserved structure, the SET domain. The sequences 
within the SET domain are not adequate for enzymatic activity. Methylation is only seen 
when two adjoining cystein-rich sequences (PRE-SET as well as POST-SET) are merged to 
the SET domain. 
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Figure 3: Families of histone lysine methyltransferase (Cosgrove et al., Nature structural 
molecular biology 2004) 
• SUV39 family and G9A: 
The most remarkable feature in this group of proteins is the occurrence of a PRE-SET domain 
in all members, and certainly the lack of such a domain in any exterior protein the SUV39 
family. The requirement of this domain for enzymatic activity suggests that this domain may 
offer specificity essential for the SET domain to methylate lysine 9 of histone H3, rather than 
any other lysine. Three members of this family (in addition to SUV39H1) have been 
recognized as histone H3 lysine 9 methyltransferases: SUV39H2, ESET and G9A. The 
chromo-domain there in SUV39 is possibly and surprisingly not present in any other SET 
domain protein. Even though it does not bind with methylated lysine 9, it is still probable that 
it may recognise additional methylated lysines in histones. Two proteins G9A and GLP1 
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encompass Ankaryn repeats that are at hand in other signalling molecules. This domain is 
considered to symbolize a protein–protein interaction surface. G9A is able to methylate lysine 
27 of histone H3 in accumulation to lysine 9. This specificity may be a trait of some enzymes 
that have multiple functions. 
 
4.    Histone acetyltransferase 
With the recognition activators and co-activators of transcription are as fanatical histone 
acetyltransferases (HATs), where it was possible now to document the associations between 
histone acetylation and gene activation in a lot of cases (Sterner and Berger, 2000; and Roth et 
al., 2001). Devoid of exception, multi-protein assemblies establish the functions, specificities 
of substrate and targeting of vital HAT subunits (Wolffe and Hayes, 1999; Nakatani and 
Ogryzko, 2001). The acetylation of histones, and its effects on structure, can be overturned by 
dedicated histone deacetylases (HDACs), and many repression phenomenons include histone 
deacetylation (Khochbin et al., 2001). Thus, the relationship between HDACs and HATs 
shows dynamic transitions in chromatin arrangement and in between switches states of its 
activity. Efficiently HATs and HDACs is highlighted by the essential regulatory roles that 
they possess deregulation which has been linked to the sequence of cancers (e.g. leukemia, 
breast cancer as well as colorectal). 
 
          4. 1 Broad, domain-wide histone acetylation: 
Acetylation of histones H3 and H4 counteract the propensity of nucleosomal fibers to fold 
into highly dense structures (Garcia and Ramirez et al., 1995 and Tse et al., 1998) and 
acetylated chromatin is more accessible to interact with proteins. Increased sensitivity of 
DNase I (Hebbes et al., 1994; Krajewski and Becker, 1998) helps in site-specific acetylation 
or deacetylation that leads to activation or repression of transcription which is restricted. In 
higher eukaryotic cells, the majority the genome contain hypoacetylated, inactive chromatin. 
Commencement of house-keeping and cell-type-specific genes involves the acetylation of 
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histones broadly across chromatin domains. Eg: -globin loci, which reveals wide 
acetylation during domains with distinct boundaries for transcriptional competence (Litt et 
al., 2001; Schübeler et al., 2001). On the other hand, histone acetylation H3/H4 leads to 
fractional decondensation of chromosomal domains. It is acknowledged that a domain which 
has been rendered 'permissive' by acetylation will never be set up close to repressive 
heterochromatic structures in nuclei. 
 
4.2 Role in gene regulation: 
Histone acetylation leads to modified folding of the nucleosomal fiber having chromosomal 
domains. The transcription machinery may be access promoters and transcription gets 
initiated. The unfolding of chromosomal domains also facilitates the transcription elongation 
itself. Nucleosomes obstruct the elongating RNA polymerase that transfers the histone 
octamers to DNA. (Studitsky et al., 1997; Orphanides and Reinberg, 2000). Transcription is 
found to falter less on nucleosomes that are hyperacetylated than on non-acetylated (Protacio 
et al., 2000). Thus, few HATs may be responsible for facilitating the elongation of 
polymerase (John et al., 2000). Histone acetylases and deacetylases at molecular level reveals 
two fundamental principles.  
• Histone acetylases included as the basic components of the Pol II machinery, where 
conscription of the Pol II machinery to promoters is associated with bringing of 
histone acetylases. 
• Few histone acetylases and deacetylases interrelated with specific DNA-binding 
activator and repressor proteins, strongly suggests that transcriptional activity is 
modulated of specific promoters by locally disturbing chromatin structure. Targeting 
of chromatin modifying activities could occur separately of the Pol II machinery.  
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• Switching between activation and repression pathways: 
Histone acetylation is a localized toggle that allows interconversion of permissive and 
repressive chromatin structures and domains. These are noy only responsibl for 
transcriptional regulation but also govern other processes concerning chromatin substrates, 
that includes replication, site-specific recombination and DNA repair (Wolffe and Hayes, 
1999; Roth et al., 2001). The switch to a permissive chromatin structure is favorable to 
similar actions between nucleosome remodeling complexes which contain ATPases of the 
SWI2/SNF2 family. The switch to repressive chromatin says about histone deacetylation, 
promoting the compression of the nucleosomal fiber and recruits repressive factors.  
 
4.3  Histone acetylation in cancer: 
Histone acetylation plays an important role in cellular processes, involving cell proliferation. It 
does not astonish that mutations or chromosomal modifications involving HATs result in to 
malignancies. An unique feature of human leukemia is the occurrence of chromosomal 
translocations showing the expression of fusion proteins, whose effects can be twofolded. 
Several translocations can inactivate the wild-type function of HATs causing the silencing of 
genes regulated by these enzymes. Also, fusion proteins derived from a HAT and a DNA-
binding protein activates genes usually not expressed. A biallelic mutation in the p300 locus 
was recognized in human epithelial cancer. The transcriptional coactivator p300/CBP 
(CREBBP) is a histone acetyltransferase (HAT) regulating expression of gene by acetylating 
histones and other transcription factors. Deregulation of p300/CBP HAT activity contributes to 
various diseases.  
 
 
 
 
 17 | P a g e  
 
4.4  p300 machinery: 
Description of p300/CBP histone acetylase (Bannister and Kouzarides 1996; Ogryzko et al. 
1996) was initially given as a transcriptional coactivator that interacts with a ample variety of 
enhancer-binding proteins (Janknecht and Hunter 1996).where it is firmly associated with the 
Pol II holoenzyme (Nakajima et al. 1997, suggest the likelihood of histone acetylase for 
transcription machinery.  
p300 and CBP function as an example of histone and factor acetyltransferases (HAT and FAT) 
by catalyzing by adding up acetyl group to definite lysine residues on histones. The function of 
the transcriptional coactivator p300 in cell cycle run was not identified till then due to the lack 
of suitable experimental systems. The research groups have brought up cell cycle succession of 
p300-deficient cancer cell lines, where p300 was disrupted either targeting gene (p300 cells) or 
removed by using RNAi. Regardless of major proliferation defects under normal growth 
conditions, p300-deficient cells progressed quickly. 
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RATIONALE BEHIND THE PROJECT 
 
Histone methylation and acetylation are the two distinct modifications in the histone tail 
wrapped by DNA (1.7nm times). Histone acetylation alters (Norton et al. 1989), which 
increases the accessibility of transcriptional regulatory proteins to chromatin (Lee et al. 1993; 
Vettese-Dadey et al. 1996). Conformation of nucleosome, with transcriptionally active genes 
carry acetylated core histone. Meanwhile, histone methylation suppress gene expression but 
help in replication and regulate DNA methylation through chromatin dependent transcription 
repression in presence of DNMT3A, DNMT3B (denovo) DNMT1 (maintenance).  
In view of the above p300 and G9A has been selected to investigate their expression levels in 
normal tissue as well as leukemia tissue 
  
 Qualitative and quantitative analysis of the expression level of histone acetylation and 
methylation . 
 Comparison of the expression level of G9A and p300 in normal blood tissue and leukemia .  
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MATERIALS AND METHOD 
 
1. Collection of Samples: 
Blood was collected as the normal tissue from the local CWS Hospital, Rourkela, Odisha, stored in ice and 
immediately processed for better RNA extraction. Leukemia (blood sample) was collected from National 
Medical College, Kolkata and stored in 4o C until RNA extraction. 
 
2. Extraction of Total RNA: 
2.1 Extraction from blood (normal tissue) using GeneJETTM RNA 
Purification Kit (Fermentas) 
The collected blood was centrifuged at 3000 rpm for 15 mins at 4° C. The supernatant containing 
the serum was separated from the pellet which contains the blood cells. The pellet was 
resuspended in 600 µl of Lysis Buffer and vortexed to mix thoroughly. 450 µl of ethanol (96-
100%) was. About 700 µl lysate was transferred to a GeneJETTM RNA Purification Column 
inserted in a collection tube and centrifuged at 12000 rpm for 1 min at 4° C. The flow-through 
was discarded and the column was placed into a new 2 ml RNase-free eppendrof. 700 µl Wash 
Buffer 1 (with 250 µl of ethanol for every 1ml Wash buffer 1) was added to the column and 
centrifuged for 1 min at 12000 rpm.The flow-through was discarded and 600 µl of Wash Buffer 2  
was added to the column. It was centrifuged at 12000 rpm for 1 min at 4° C. The flow-through 
was again discarded. Centrifugation was again done at 12000 rpm for 1 min at 4 ° C by adding 
250 µl of Wash buffer 2. The flow-through was discarded and the column was transferred to a 
sterile 1.5 RNase-free eppendrof. With addition of 100 µl nuclease-free water to the column and 
for 1 min at 12000 rpm it was centrifuged to elute RNA. The RNA was stored at - 20° C for 
further use or immediately processed for cDNA synthesis. 
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    2.2  Extraction from blood lymphocyte (normal tissue) using manual method: 
    The required reagents are as follows: 
Chloroform:isoamylalcohol  (49:1), Ethanol, isopropanol , PBS ,CH3COONa (2M) at pH 4, 
solution D, 4M Guanidium thiocyanate (118.16g), 25MM sodium citrate (253.11g), 0.5% W/V 
sarcocyanate (293.38g),0.1M  β-mercapto ethanol . 
For this mRNA isolation blood sample was collected and centrifuged at 3000 rpm for 10 mins 
(room temperature) and PBS was added centrifuged under the same condition. Discarding the 
supernatant, 2 ml of solution D was added for 106 cells .The cells were homogenized for 15 to 30 
secs in room temperature and 0.1ml of 2M sodium acetate was added, where 1ml of phenol 0.2ml 
of chloroform:isoamylalcohol per milliliter of solution D was mixed. The mixture was gently 
vortexed and homogenized for 10 seconds, the tube was incubated for 15 mins on ice to permit 
complete dissociation of cellular protein complex. Thereafter, the tube was centriguged at 9000 
rpm for 20 mins at 4°C and the extracted RNA in upper aqueous solution was collected. Equal 
volume of isopropanol to the extracted RNA was mixed the RNA was allowed to precipitate for 1 
min at 20 °C and centrifuged at 9000 rpm at 4°C for 30 min. Carefully the isopropanol was 
decanted and the RNA pellets was dissolved in 0.3ml and solution D for every 1ml of solution 
used in first step .The solution was then transferred to microcentrifuge tube and incubated at 20ºC 
for 1 hour. The precipitated RNA was collected and centrifuged at maximum speed for 10 mins at 
4°C. Pellets were then washed with 75% of ethanol twice. It was then centrifuged again ethanol 
was removed and it was let to air-dry. 
 
   2.3  Extraction from blood (normal tissue) using TRIZOL: 
Reagents taken were DEPC-treated water, TRIzol Reagent, cold PBS, 70% ethanol and Isopropyl 
alcohol. Tissue samples were homogenized in 1 ml of TRIZOL reagent per 50 to 100 mg of 
tissue. The sample volume should not exceed 10% of the volume of TRIZOL Reagent used for the 
homogenization. Cell monolayer was rinsed with ice cold PBS once.  An insufficient amount of 
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TRIZOL Reagent may result in DNA contamination of the isolated RNA. Cells were spinned for 
5 min at 300 X g and media was removed and cells were resuspend in ice cold PBS. We got cells 
pellet by spinning at 300 X g for 5 min. Cells were lysed with TRIZOL Reagent by repetitive 
pipetting or by passing through syringe and needle. The homogenized sample was incubated for 5 
minutes at room temperature to permit the complete dissociation of nucleoprotein complexes. 
Centrifuged to remove cell debris and the supernautant was transferred to new tube. 0.2 ml of 
chloroform was added per 1 ml of TRIZOL Reagent. Samples vortexed vigorously for 15 seconds 
and incubated at room temperature for 2 to 3 minutes. The samples were centrifuged at 12,000 x g 
for 15 minutes at 2°C to 8
0
C. After centrifugation, the mixture gets separated into lower red, 
phenol-chloroform phase,  interphase, and a colorless upper aqueous phase where RNA remains 
exclusively in the aqueous phase. Upper aqueous phase was transferred carefully without 
disturbing the interphase into fresh tube (The volume of the aqueous phase is about 60% of the 
volume of TRIZOL Reagent used for homogenization). RNA from the aqueous phase by mixing 
with isopropyl alcohol precipitated. 0.5 ml of isopropyl alcohol was used per 1 ml of TRIZOL 
Reagent used for homogenizing initially. Samples incubated at 15 to 30
o
C for 10 minutes and 
centrifuged at 12,000 x g for 10 minutes at 2 to 4
o
C. The RNA precipitated, forms a gel-like pellet 
on the side and bottom of the tube and the supernatant was removed completely and RNA pellet 
was washed once with 75% ethanol, adding at least 1 ml of 75% ethanol per 1 ml of TRIZOL 
Reagent used for the initial homogenization.The samples were mixed by vortexing and centrifuge 
at no more than 7,500 x g for 5 minutes at 2 to 8 
o
C. RNA pellet was air dried for 5-10 minutes. 
   
    2.4  Extraction from Leukemia (blood sample): 
At least 106 cells are used, the media is aspirated off and washed with ice cold PBS (1-2 ml). The 
PBS (Remove as much as possible) was aspirated and 1 ml of Trizol was added. Trizol was 
removed with a pipette and the Trizol/cell lysate was allowed to set into a 1.5 ml Eppendorf tube. 
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5 min at room temperature it was left to sit. 250 µl of chloroformwas added and the tube was 
shaken vigorously for about 15 seconds. Centrifµged at 10,000 rpm for 5 minutes. 
At this point, there were three layers in each tube: 
Top layer: Clear – aqueous 
Middle layer / interphase - white precipitated DNA 
Bottom layer – pink organic phase 
Aqueous phase was carefully removed and 550 µl of isopropanol was added to the aqueous phase 
and mixed gently. This was centrifuged at maximal speed (14,000 rpm) for 20 minutes. If a low 
yield is expected, centrifuge for 30 minutes. Remove and place on ice. There was pellet barely 
visible at the base of each tube. The isopropanol was poured off 1 ml of 75% EtOH was added in 
DEPC treated H20 and recentrifuged at 9500 rpm for 5 minutes. EtOH was poure off  the pellets  
were left to air-dry. 
 
3.  Quantitative Estimation of RNA Concentration 
The concentration of the extracted total RNA from both blood and leukemia tissue was 
quantified by measuring the absorbance at 260 nm in a Nanodrop (Eppendrof, biophotometre 
plus) and calculated by using the formula as given below: 
Total RNA (µg /ml) = OD260 × 40 × Dilution factor 
 
4.  Quantitative Estimation of RNA Concentration by Denaturing Gel 
Electrophoresis: 
The extracted RNA from both blood and cancer tissue was run on a denaturing agarose gel and 
the quantity of RNA estimated from the band intensity. For denaturation gel (40 ml), 0.6g 
agarose (Sigma), 28.8 ml dH2O (Sigma), 7.2 ml formaldehyde (Sigma), 4 ml 10X MOPS buffer 
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were mixed properly. About 2 µl (2µg) of the total RNA was mixed with 18 µl 1X Reaction 
Buffer (2µl of 10X MOPS Buffer and 4 µl formaldehyde with10 µl formamide (Sigma) and 2 µl 
0.2 mg/ml Etbr (Sigma)) and incubated at 55 °C for 1 hr. It was then cooled on ice and loaded in 
the wells of the denaturing gel. 
 
5. First strand cDNA synthesis: 
Total RNA (4 µg) from both blood and cancer tissue were used for first strand cDNA synthesis 
by reverse transcription using RevertAidTM First Strand cDNA Synthesis Kit (Fermentas) in a 
thermocycler. The RNA was incubated with 1 µl of oligo(dT) primers (100 µM, 0.2 µg/µl) and 
12 µl of nuclease-free water at 65°C for 5 min. The reaction was cooled on ice to allow the 
primers to anneal to the RNA, it is spinned and placed on ice again after which the following 
components were added to the reaction in order; 4 l of 5X Reaction Buffer, 1 l of RibolockTM 
RNase inhibitor (20 U/ l), 2 l of 10 mM dNTPs and 1.0 L of RevertAidTM M-MuLV-Reverse 
Transcriptase (200 U/ l). The reagents were gently mixed and incubated for 1 hr at  
42° C. Heating at 70° C for 5 min terminated the reaction and the synthesized cDNA was stored 
at –20 0 C for further use. 
 
6. Gene-specific PCR for amplification of the desired gene: 
      6.1. Primers selection: 
A set of specific forward and reverse primers for the amplification of the desired gene under 
study was selected from published papers (Makoto Tachibana and Kenji Sugimoto, 2001). The 
cDNA of both the blood and leukemia tissue synthesized were used as the template for the 
specific primers which are specific. The housekeeping gene, β-actin which is consecutively 
expressed was used to positively control and ensures high quality. The following are the primer 
sequences used for the PCR reaction : 
 
 24 | P a g e  
 
GENE FORWARD PRIMER REVERSE PRIMER 
G9A 5’ATAGAATTCGATGGCGGAAAATTTAAAG3’ 5’ATAGAATTCCTAGAAGAGGTATTTTCGGCA3’  
 
p300 5’GACCCTCAGCTTTTAGGAATCC3’  5’TGCCGTAGCAACACAGTGTCT3’  
β-actin 5’TCTACAATGAGCTGCGTGTG3’  5’ATCTCCTTCTGCATCCTGTC3’  
 
Table 2.Table showing the sequence of the forward and backward primers used 
      6.2 PCR conditions: 
The PCR sample mixtures, in a 25 µl volume, contained 17 µl of dH2O (Sigma), 2.5 µl of 1X 
PCR buffer (Sigma), 0.5 µl of dNTP (0.2 mM, Sigma), 1.5 µl of MgCl2 (1.5 mM, Sigma), 0.5 µl 
each of the forward and reverse primers (0.2 µM, Sigma) of p300 and G9A and 0.5 µl Taq 
DNA-polymerase (1U/µl, Himedia). 2 µl of each cDNA sample was added. PCR amplifications 
of p300 and G9A and β-actin were performed in a thermal cycler by initial denaturation at 94° C 
for 1 min which was followed by 30 cycles of denaturation at 94° C for 20 secs, annealing at   
57 ° C for 20 secs, and extension at 72° C for 30 secs, followed by an final extension step at 72° 
C for 5 mins. For amplification of G9A, the following conditions were followed: initial 
denaturation at 95° C for 5 mins and prior to 30 cycles of denaturation at 94° C for 30 secs, 
annealing at 57 ° C for 20 secs, and extension at 72° C for 45 secs then followed by an final 
extension step at 72° C for 10 mins. 
 
7.  Agarose Gel Electrophoresis of the PCR products: 
The generated PCR products were analyzed by electrophoresis on 1.5% agarose gel. Agarose gel 
was prepared with 1X TAE (Tris Acetate EDTA, Sigma) buffer. Before casting 0.1% ethidium 
bromide was added to the gel. 15 µl of sample (PCR product) was loaded to each well along 
with 3 µl 1 X of loading dye. 5 µl of DNA marker (1 kb, Sigma) and the gel was run in TAE 
buffer at 100 volt for 40 minutes. 
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8.  Analysis of the Relative Expression level of the different genes: 
The relative levels of expression of each gene were analyzed by taking the absorbance through s 
readings taken in Nanodrop. The ratios of desired genes/β-actin product were subsequently 
calculated after subtraction of the background pixel intensity for each gene of interest and used 
to assess the differences in expression levels between normal and leukemia tissue. 
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RESULT AND DISCUSSION 
1. Quality Check of RNA Isolated from Normal And Leukemia   
Samples: 
 
The concentration of the extracted total RNA from normal tissue and leukemia tissue was 
estimated by taking OD260nm/OD280nm, which was found to be 234.32 µg/ml for normal tissue 
and 188.8µg/ml for leukemia tissue. Further integrity of the RNA samples was checked by RT-
PCR using β-Actin primer pairs.  
1 2    
                                
                                (A) 
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                 1            2         3           4 
                    
                                (B)                         
Figure 4: The gel photograph of total RNA extracted (A) in 1.2% Agarose gel  
                (B) Denaturing gel electrophoresis  
2.  Gene Specific Amplification: 
The PCR products obtained by gene specific amplification were run in a 1.2% agarose gel. The 
results obtained are given below. The expression of β-actin (663 bp) proves the integrity of the 
RNA extracted. 
                          1           2         3          4 
                                                 
Figure 5: The gel photograph of the expression of β-actin 
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                       1         2          3  1   2    3 
                                                    
(A)                                                              (B) 
Figure 6: The gel-doc photograph of the expression of p300 in (A) Normal blood tissue,  
                  and (B) Leukemia tissue after gene-specific amplification seen in a 1.2% 
                 agarose gel 
                1         2       3                              1       2        3      
                            
(A)                                            (B) 
Figure 7: The gel-doc photograph of the expression of G9A at 384bp in (A) Normal blood    
                  (B) Leukemia tissue after gene-specific amplification seen in a 1.2% agarose gel 
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The gene expression of p300 and G9A in blood and leukemia tissue was analyzed in                
(Figure 5 and 6). It was observed that p300 as well as G9A was highly expressed in leukemia 
tissue. The expression of p300 is yet to be clarified which is due to interaction with DNA- 
binding transcriptional activation domains. Encoding for histone acetyltransferase deregulation in 
p300 occurs with hypermethylation of H3K9Me3, H3K9Me2, H3K36Me3, and H3K36Me2. 
G9A which indirectly takes part in histone methylation being domain of SET family. This 
generally leads to hypermethylation due to the adjacent cysteine rich regions essential for histone 
methyltransferase activity. 
     A coordinated endeavor between basic molecular biology functional genomics and proteomics 
and cell signaling may  provide information on the relationship of this upregulation and 
downregulation with different epigenetically  modulating genes such as HATs, HDACs, HMTs 
etc and elucidate their concerted action in Cancer  etiology. 
Therapeutic targeting of the methyltranferase and acetytransferase activity for treatment of 
leukemia and other anomalies associated with aberrant Methylation and Acetylation. 
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CONCLUSION 
 
The association of eukaryotic chromatin has a major impact on all nuclear processes concerning 
DNA substrates. The positioning of individual nucleosomes relative to regulatory sequence elements, 
affects the gene expression by the folding of the nucleosomal fiber keen on higher-order structures 
by the compartmentalization of functional domains contained by the nucleus. p300, a histone 
acetyltransfarase, act as transcriptional activator. It was found in leukemia cells that the presence of 
chromosomal translocations leading to the expression of fusion proteins which can trigger genes 
usually not expressed. Translocations can inactivate the wild-type function of HATs causing the 
silencing of genes synchronized by the enzymes.  
                                                                           NORMAL 
 
                          ABERRATIONS (Mutation, carcinogens, Induced UV radiations) 
 
                                                TRANSFORMED 
 
                   H3K9 trimethylation mark and                                p300 is overexpressed 
                             G9A is overexpressed 
 
Heterochromatinization of tumour suppressor gene             Acetylation at the promoter region 
 
                                                          LEUKEMIA 
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